Gilead disputes report of anti-viral drug remdesivir failing Covid-19 trial
It comes days after another report of rapid recovery in fever and respiratory symptoms in some patients with Covid-19 who were treated with remdesivir at the University of Chicago Medicine hospital
No comments:
Post a Comment